Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940

Classificação em ações #496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Preço da ação
$1,028.49
Valor de mercado
$47.88B
Variação (1 dia)
-3.67%
Variação (1 ano)
-18.37%
País
KR
Negociar Samsung Biologics Co.,Ltd. (207940)

Categoria

Healthcare
Rácio P/S de Samsung Biologics Co.,Ltd. (207940)
Rácio P/S em October 2026 TTM: 14.48
De acordo com os relatórios financeiros mais recentes e o preço das ações da Samsung Biologics Co.,Ltd., o rácio P/S atual (TTM) é 14.48. No final de 2024, o rácio P/S era 19.31.
Histórico do rácio P/S da Samsung Biologics Co.,Ltd. de 2014 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
2026 (TTM) 14.48 -15.84%
2025 17.20 -10.95%
2024 19.31 27.07%
2023 15.20 -20.91%
2022 19.22 -50.09%
2021 38.51 -18.79%
2020 47.42 14.90%
2019 41.27 -11.58%
2018 46.67 -16.73%
2017 56.06 83.95%
2016 30.47 -74.24%
2015 118.31 15.20%
2014 102.70 0.00%
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
10.72 -25.93%
US
41.70 188.07%
US
4.19 -71.05%
AU
5.80 -59.96%
BE
10.44 -27.86%
NL